// The Internet's Most Complete GLP-1 Resource
GLP-1 is one of the most talked-about topics in health — but most people still aren't sure exactly what it is. This guide explains it clearly, honestly, and completely.
Enter your info and a clinician will reach out with a personalized overview — no pressure, no obligation.
A clinician from Elevation Health will be in touch shortly.
GLP-1 stands for Glucagon-Like Peptide-1 — a hormone your body naturally produces in your gut after eating. It signals your brain that you're full, slows digestion, and helps regulate blood sugar by stimulating insulin release. GLP-1 receptor agonist medications are lab-developed compounds that mimic this hormone — giving your body more of its natural "stop eating" signal in a controlled, clinically-supervised way.
GLP-1 isn't a new invention. It's a hormone your body has always produced. The breakthrough is learning how to harness it therapeutically.
Your intestinal L-cells detect the nutrients. They begin releasing GLP-1 into your bloodstream within minutes of eating.
GLP-1 crosses into your hypothalamus — the brain's appetite control center — activating receptors that send a satiety signal. You feel full sooner.
GLP-1 stimulates insulin release in response to food — but only when blood sugar is elevated. This glucose-dependent action makes it very precise.
The problem? In people with obesity or metabolic dysfunction, the natural GLP-1 response is often blunted or too short-lived. GLP-1 medications fill that gap — giving your biology the signal it may not be producing effectively on its own.
The world of GLP-1 comes with a lot of jargon. Here's what the most important terms actually mean — in plain English.
A medication that activates GLP-1 receptors in the body — just like the natural hormone does. "Agonist" simply means it binds to and activates the receptor. Examples include semaglutide and tirzepatide.
A GLP-1 receptor agonist used in Ozempic (injection, originally for type 2 diabetes) and Wegovy (injection, for weight management). It's also available in a compounded injectable or oral form through licensed telehealth providers.
A dual-action medication (GLP-1 and GIP receptor agonist) used in Mounjaro and Zepbound. Studies suggest tirzepatide may produce greater average weight loss than semaglutide alone.
A version of semaglutide or tirzepatide prepared by a licensed compounding pharmacy. Compounded options can be significantly more affordable than brand-name versions and are prescribed through authorized telehealth providers.
A class of gut-derived hormones — including GLP-1 and GIP — that stimulate insulin secretion after eating. GLP-1 is the most well-studied incretin and is the basis for an entire class of modern metabolic medications.
The rate at which food moves from your stomach into the small intestine. GLP-1 medications slow this process, which contributes to prolonged feelings of fullness and a more gradual rise in blood sugar after meals.
How effectively your cells respond to insulin to absorb glucose. Poor insulin sensitivity (insulin resistance) is common in obesity and type 2 diabetes. GLP-1 medications can help improve this over time.
The process of starting at a low dose and gradually increasing over weeks to months. This approach helps minimize side effects (especially nausea) while allowing the body to adjust. All GLP-1 protocols are physician-titrated.
A second incretin hormone. Tirzepatide targets both GLP-1 and GIP receptors simultaneously, which may explain its greater efficacy in clinical trials compared to GLP-1-only medications.
The brain-based process of feeling satisfied and no longer hungry. GLP-1 activates satiety receptors in the hypothalamus — the part of the brain that regulates appetite and energy balance.
GLP-1 receptor agonists work on multiple systems at once. That's why the results can be more significant than traditional approaches.
GLP-1 activates receptors in the hypothalamus that reduce hunger signals. Many patients report thinking about food far less frequently — even with smaller portions.
GLP-1 slows how quickly your stomach empties after eating. This means you feel full longer and experience fewer blood sugar spikes — potentially reducing cravings for high-carb foods.
GLP-1 stimulates the pancreas to release insulin — but only in response to elevated blood sugar. This glucose-dependent action may reduce the risk of hypoglycemia (low blood sugar).
GLP-1 suppresses glucagon — the hormone that tells your liver to release stored sugar into the bloodstream. This helps prevent post-meal glucose surges even when you do eat carbohydrates.
The two most common GLP-1 medications — and how they differ.
| Feature | Semaglutide (Ozempic / Wegovy) | Tirzepatide (Mounjaro / Zepbound) |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 + GIP receptor agonist |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
| Avg. Weight Loss (clinical trials) | ~15% body weight (Wegovy STEP trial) | ~20–22% body weight (SURMOUNT trial) |
| FDA-Approved For | Type 2 diabetes & obesity (separate formulations) | Type 2 diabetes & obesity (separate formulations) |
| Compounded Version Available | ✓ Yes | ✓ Yes |
| Cardiovascular Benefit Evidence | ✓ Strong (SELECT trial) | ✓ Emerging (SURPASS-CVOT) |
| Common Side Effects | Nausea, constipation, fatigue (early weeks) | Similar nausea/GI effects, often better tolerated |
Sources: NEJM STEP-1 Trial · NIH ClinicalTrials SURMOUNT. Data reflects published peer-reviewed research.
GLP-1 medications aren't right for everyone — and that's by design. A physician reviews your full health picture before any prescription is issued.
GLP-1 medications are FDA-approved for adults meeting specific clinical thresholds and seeking physician-supervised weight loss support.
GLP-1 medications were originally developed for type 2 diabetes and remain an evidence-based tool for metabolic improvement.
GLP-1 medications may not be suitable for everyone. A physician will review your history before prescribing.
The team at Elevation Health offers a free consultation to review your health history and goals. They'll tell you honestly whether GLP-1 therapy may be a fit — no pressure, no upsell. Lindsay and Meredith are registered dietitians with 15+ years of clinical experience in metabolic health and peptide therapy.
Book a Free Consultation at Elevation Health →GLP-1 therapy isn't an overnight fix — but the progression is well-documented and consistent for most patients.
Most protocols begin at the lowest dose. Mild nausea may occur as your body adjusts — this typically improves significantly by week 3 or 4. Appetite reduction often begins within the first two weeks.
Your physician may increase the dose incrementally. This is a critical window for building the nutrition and lifestyle habits that make weight loss sustainable long-term. Dietitian-led programs like Elevation Health's GLP-1 360 Plan focus here heavily.
Clinical studies show the most significant weight loss typically occurs between months 3 and 6. Patients may potentially see 10–15% or more total body weight reduction, along with improvements in blood sugar, blood pressure, and metabolic markers.
At this stage, physicians assess whether continued therapy, dose reduction, or tapering is appropriate. The goal of a good GLP-1 program is not dependency — it's metabolic reset. Structured programs include exit planning from day one.
These are real experiences from Elevation Health clients. Individual results always vary.
"Working with actual dietitians changed everything. I finally have a structured plan that makes sense for my body — not a one-size-fits-all approach."
"The biggest shift was the clarity. Having someone analyze my labs and build a protocol around my data gave me confidence I'd never had with other providers."
"I appreciated the structured oversight. Every check-in felt intentional, and I always knew exactly where I stood and what was next."
Individual experiences vary. Testimonials reflect personal opinions and are not intended to represent or guarantee specific outcomes. All care is provided under physician oversight.
These are the questions real people search for most. We've answered each one thoroughly — and without the marketing spin.
Harvard Medical School has published extensive educational content on GLP-1 receptor agonists and their role in metabolic health. It's an excellent non-commercial resource for anyone wanting to understand the science further.
Read Harvard Health's GLP-1 Overview →Lindsay and Meredith are registered dietitians with over 15 years of clinical experience each in nutrition, metabolic health, and peptide therapy.
They founded Elevation Health to bridge the gap between prescriptive weight loss and true metabolic optimization — a model where every client receives the depth of care they deserve.
🔒 Physician-prescribed · U.S. licensed pharmacy · Discreet delivery
Lindsay & Meredith
Registered Dietitians · 15+ Years Each
Co-Founders, Elevation Health
Start with a free consultation. A registered dietitian will review your goals and health history — and give you an honest answer about whether GLP-1 therapy may be a fit.
A clinician will reach out to you shortly. Check your inbox.